Endometrial cancer recurrence study after surgery without lymph node removal
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at whether women with a very low-risk type of endometrial cancer can safely skip lymph node removal during surgery. It aims to see if the cancer stays away for at least 3 years after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have endometrioid-type endometrial cancer, a common type that starts in the lining of the uterus.
- Your doctor plans surgery that does not remove lymph nodes (small glands that help fight infection).
- You have had a pelvic MRI and a blood test for CA125, and the results meet the study's criteria.
- The cancer has not spread to other parts of the body.
- You are 19 years old or older.
- You have not had another cancer in the last 5 years, and you have not had a hysterectomy or previous treatment for endometrial cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This is an observational study that follows people with endometrial cancer who have had surgery to check and remove pelvic (and sometimes paraaortic) lymph nodes. It looks at how different surgical approaches and any added treatment affect local control (keeping cancer from coming back in the pelvis/nearby areas).
This study compares two ways of removing lymph nodes during surgery for a high-risk type of uterine (endometrial) cancer with a p53 gene mutation. You would be randomly assigned to either removing only the sentinel (first few) lymph nodes or removing many lymph nodes, to see if the less invasive approach is just as good.
This trial compares two ways of removing lymph nodes during a vaginal minimally invasive surgery for early-stage endometrial cancer. It aims to find which method is safer and more effective.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.